| Literature DB >> 33215740 |
Lilian M Fennell1, Carlos Gomez Diaz1, Luiza Deszcz1, Anoop Kavirayani2, David Hoffmann1, Kota Yanagitani3, Alexander Schleiffer1,4, Karl Mechtler1,4, Astrid Hagelkruys1, Josef Penninger1,5, Fumiyo Ikeda1,3.
Abstract
HOIP, the catalytic component of the linear ubiquitin chain assembly complex (LUBAC), is a critical regulator of inflammation. However, how HOIP itself is regulated to control inflammatory responses is unclear. Here, we discover that site-specific ubiquitination of K784 within human HOIP promotes tumor necrosis factor (TNF)-induced inflammatory signaling. A HOIP K784R mutant is catalytically active but shows reduced induction of an NF-κB reporter relative to wild-type HOIP. HOIP K784 is evolutionarily conserved, equivalent to HOIP K778 in mice. We generated HoipK778R/K778R knock-in mice, which show no overt developmental phenotypes; however, in response to TNF, HoipK778R/K778R mouse embryonic fibroblasts display mildly suppressed NF-κB activation and increased apoptotic markers. On the other hand, HOIP K778R enhances the TNF-induced formation of TNFR complex II and an interaction between TNFR complex II and LUBAC. Loss of the LUBAC component SHARPIN leads to embryonic lethality in HoipK778R/K778R mice, which is rescued by knockout of TNFR1. We propose that site-specific ubiquitination of HOIP regulates a LUBAC-dependent switch between survival and apoptosis in TNF signaling.Entities:
Keywords: HOIP E3 ligase; TNF; apoptosis; linear ubiquitination; skin inflammation
Mesh:
Substances:
Year: 2020 PMID: 33215740 PMCID: PMC7737615 DOI: 10.15252/embj.2019103303
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 14.012